Enterprise IT & Analytics

My devices need
to talk.

Helping hospitals leverage their medical device and HIT investments.

Infection Prevention

Fighting HAIs can feel like an uphill battle.

Let CareFusion help. Providing a systematic approach to target preventable HAIs.*

Medication Management

The cure for the common med system

Preventing errors and controlling medication inventory throughout the hospital.

OR Effectiveness

Improving the financial health of the operating room.

Comprehensive solutions that span sterile processing to post-procedure.

Respiratory Care

Helping patients breathe easy. And caregivers too.

Targeted lung protective solutions to help improve patient outcomes.

Key success factors for
HAI webinar

December 4, 2014, 3 pm ET/12 Noon PT
Review current progress in HAI initiatives and identify the key success factors. Register Now

3100A HFOV and iNO Webinar

December 3, 2014, 8 − 9 a.m. PST
Learn respiratory strategies for neonates using the 3100A HFOV. Register Now

Find out what we've
been up to… and
where we're going.

Register today for our biggest invite-only
event at ASHP. Register now

CareFusion is your
partner in Quality Care

Visit booth 140 at AARC Congress,
December 9–12, 2014 in
Las Vegas, NV. Learn more

Spotlight

CareFusion Reports First Quarter Fiscal 2015 Results

CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended Sept. 30. "Our team started the year...

BD to Acquire CareFusion for $12.2 Billion

Franklin Lakes, NJ and San Diego, CA (October 5, 2014) – BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions. The agreement has been unanimously approved by the Boards of both companies.

CareFusion Announces Completion Of Post-Market Surveillance For MaxPlus® Positive Displacement Needleless Connectors

CareFusion (NYSE:CFN), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has notified the company that it has fully  completed its obligations for Post-market Surveillance Studies for the MaxPlus® line of positive displacement needleless connectors.

CareFusion Launches Application to Help Clinicians Improve Patient Care for Mechanically Ventilated Patients

SAN DIEGO, Aug. 8, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the availability of a new capability on the CareFusion Respiratory Knowledge...

CareFusion Reports Fourth Quarter And Fiscal 2014 Results

CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014, provided guidance for fiscal 2015, its...

Read more >


Product Alerts: Medical device recalls and other notices More



* CareFusion technologies may help hospitals reduce the risk of certain infections when used in conjunction with other clinical best practices and interventions.

Get Support

  • U.S. Customers:

  • Global Customers:

 

Upcoming Events

December 2–5, 2014
AMSUS, the Association of Military Surgeons of the United States

December 8–10, 2014
ASHP, American Society of Health System Pharmacists

December 9–12, 2014
AARC, American Association for Respiratory Care

January 25–27, 2015
STS, Society of Thoracic Surgeons

January 26–29, 2015
Arab Health

February 25–28, 2015
AAHPM, American Academy of Hospice and Palliative Medicine

View All >